AP32A - Pharmaceutically active compounds and a method for its preparation - Google Patents

Pharmaceutically active compounds and a method for its preparation Download PDF

Info

Publication number
AP32A
AP32A APAP/P/1985/000017A AP8500017A AP32A AP 32 A AP32 A AP 32A AP 8500017 A AP8500017 A AP 8500017A AP 32 A AP32 A AP 32A
Authority
AP
ARIPO
Prior art keywords
disease
accordance
preparation
pharmacological
treatment
Prior art date
Application number
APAP/P/1985/000017A
Other languages
English (en)
Other versions
AP8500017A0 (en
Inventor
Borje Rosen
Kurt Leander
Original Assignee
Conpharm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of AP8500017A0 publication Critical patent/AP8500017A0/xx
Application filed by Conpharm Ab filed Critical Conpharm Ab
Application granted granted Critical
Publication of AP32A publication Critical patent/AP32A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1985/000017A 1984-12-28 1985-12-23 Pharmaceutically active compounds and a method for its preparation AP32A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28

Publications (2)

Publication Number Publication Date
AP8500017A0 AP8500017A0 (en) 1985-11-01
AP32A true AP32A (en) 1988-12-07

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1985/000017A AP32A (en) 1984-12-28 1985-12-23 Pharmaceutically active compounds and a method for its preparation

Country Status (23)

Country Link
US (1) US4788216A (fr)
EP (1) EP0207124B1 (fr)
JP (2) JPH0720966B2 (fr)
CN (1) CN1006795B (fr)
AP (1) AP32A (fr)
AT (1) ATE68186T1 (fr)
AU (1) AU585936B2 (fr)
CA (1) CA1255230A (fr)
DE (1) DE3584370D1 (fr)
DK (1) DK169506B1 (fr)
DZ (1) DZ876A1 (fr)
EG (1) EG17788A (fr)
ES (1) ES8701761A1 (fr)
FI (1) FI89330C (fr)
GR (1) GR853145B (fr)
HU (1) HU201672B (fr)
IL (1) IL77456A (fr)
MA (1) MA20602A1 (fr)
NO (1) NO863329L (fr)
PT (1) PT81760B (fr)
TN (1) TNSN86004A1 (fr)
WO (1) WO1986004062A1 (fr)
ZA (1) ZA859881B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
DE69033342T2 (de) * 1989-02-23 2000-05-11 Univ North Carolina Etoposidanaloge
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) * 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
DE60233601D1 (de) * 2001-06-19 2009-10-15 Axelar Ab Verwendung von bestimmten Cyclolignanen
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
EP2303261A4 (fr) * 2008-06-23 2011-09-07 Axelar Ab Utilisation de cyclolignanes pour le traitement d un système immunitaire hyperactif
WO2013124380A1 (fr) * 2012-02-24 2013-08-29 Nestec S.A. Peltatine destinée à être utilisée pour traiter des troubles inflammatoires chroniques
WO2015028456A1 (fr) * 2013-08-28 2015-03-05 Nestec S.A. Modulateurs des rapp
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634459A (en) * 1964-08-12 1972-01-11 Sandoz Ltd Epipodophyllotoxin derivatives
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634459A (en) * 1964-08-12 1972-01-11 Sandoz Ltd Epipodophyllotoxin derivatives
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone

Also Published As

Publication number Publication date
DK408186A (da) 1986-08-27
NO863329D0 (no) 1986-08-19
US4788216A (en) 1988-11-29
FI89330B (fi) 1993-06-15
ATE68186T1 (de) 1991-10-15
ES550504A0 (es) 1986-12-01
HUT47582A (en) 1989-03-28
IL77456A0 (en) 1986-08-31
ZA859881B (en) 1986-09-24
JP2572558B2 (ja) 1997-01-16
EP0207124A1 (fr) 1987-01-07
CN85109666A (zh) 1986-10-29
CA1255230A (fr) 1989-06-06
FI89330C (fi) 1993-09-27
HU201672B (en) 1990-12-28
GR853145B (fr) 1986-04-29
MA20602A1 (fr) 1986-07-01
PT81760A (en) 1986-01-02
AU5300386A (en) 1986-07-29
JPH07173063A (ja) 1995-07-11
PT81760B (pt) 1987-11-11
IL77456A (en) 1989-07-31
NO863329L (no) 1986-08-19
JPH0720966B2 (ja) 1995-03-08
WO1986004062A1 (fr) 1986-07-17
EP0207124B1 (fr) 1991-10-09
TNSN86004A1 (fr) 1990-01-01
JPS62501360A (ja) 1987-06-04
DK408186D0 (da) 1986-08-27
DK169506B1 (da) 1994-11-14
DE3584370D1 (de) 1991-11-14
CN1006795B (zh) 1990-02-14
FI863482A0 (fi) 1986-08-27
AP8500017A0 (en) 1985-11-01
DZ876A1 (fr) 2004-09-13
AU585936B2 (en) 1989-06-29
FI863482A (fi) 1986-08-27
EG17788A (en) 1990-12-30
ES8701761A1 (es) 1986-12-01

Similar Documents

Publication Publication Date Title
AP32A (en) Pharmaceutically active compounds and a method for its preparation
CA1302270C (fr) Agent carcinostatique
CN1416428A (zh) 具有抗肿瘤活性的化合物、其制备方法以及含有该化合物的药物组合物
CA2325779C (fr) Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0327590A1 (fr) 7-deazaguanines ayant une activite d'immunomodulateurs
CA2226340A1 (fr) Medicament destine a soigner les affections du cerveau
EP1353926B1 (fr) Derives de mikanolide, leur preparation et leurs applications therapeutiques
US3652567A (en) Quinazolinone derivative and process for the production thereof
JPS62267230A (ja) 抗ウイルス剤
EP0099091B1 (fr) Héxahydrodioxopyrimidines, leur préparation et utilisation
EP0556245A1 (fr) Utilisation de derives de la thiazoloisoindolinone comme medicaments antiviraux.
EP1297835B1 (fr) Dérivés de benzo[b]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US3094462A (en) Therapeutic reaction complex for muscle relaxation
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
EP0432630B1 (fr) Agent antitumoral
US5449684A (en) Cytotoxic compounds
JPH04264092A (ja) シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途
JP3068175B2 (ja) イソチアゾロ〔５，４―ｂ〕ピリジン誘導体
JPS645597B2 (fr)
KR950013764B1 (ko) 피로글루타미드 유도체, 그 제조방법, 및 그것을 함유하는 치매증 치료제
JPS6176432A (ja) 新規アズレン誘導体およびこれを含有する抗腫瘍剤
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途
KR840000910B1 (ko) 술포늄 화합물의 제조방법
JPH0366690A (ja) フロ〔３，４―ｃ〕ピリジン誘導体の不斉合成製造法
JPH09208467A (ja) トリアゾロプリン化合物を含有する抗腫瘍剤